![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
17
PharmaCompass offers a list of Esketamine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Esketamine Hydrochloride manufacturer or Esketamine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Esketamine Hydrochloride manufacturer or Esketamine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Esketamine Hydrochloride API Price utilized in the formulation of products. Esketamine Hydrochloride API Price is not always fixed or binding as the Esketamine Hydrochloride Price is obtained through a variety of data sources. The Esketamine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (-)-Ketamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (-)-Ketamine, including repackagers and relabelers. The FDA regulates (-)-Ketamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (-)-Ketamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (-)-Ketamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (-)-Ketamine supplier is an individual or a company that provides (-)-Ketamine active pharmaceutical ingredient (API) or (-)-Ketamine finished formulations upon request. The (-)-Ketamine suppliers may include (-)-Ketamine API manufacturers, exporters, distributors and traders.
click here to find a list of (-)-Ketamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (-)-Ketamine DMF (Drug Master File) is a document detailing the whole manufacturing process of (-)-Ketamine active pharmaceutical ingredient (API) in detail. Different forms of (-)-Ketamine DMFs exist exist since differing nations have different regulations, such as (-)-Ketamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (-)-Ketamine DMF submitted to regulatory agencies in the US is known as a USDMF. (-)-Ketamine USDMF includes data on (-)-Ketamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (-)-Ketamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (-)-Ketamine suppliers with USDMF on PharmaCompass.
A (-)-Ketamine CEP of the European Pharmacopoeia monograph is often referred to as a (-)-Ketamine Certificate of Suitability (COS). The purpose of a (-)-Ketamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of (-)-Ketamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of (-)-Ketamine to their clients by showing that a (-)-Ketamine CEP has been issued for it. The manufacturer submits a (-)-Ketamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a (-)-Ketamine CEP holder for the record. Additionally, the data presented in the (-)-Ketamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the (-)-Ketamine DMF.
A (-)-Ketamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. (-)-Ketamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of (-)-Ketamine suppliers with CEP (COS) on PharmaCompass.
A (-)-Ketamine written confirmation ((-)-Ketamine WC) is an official document issued by a regulatory agency to a (-)-Ketamine manufacturer, verifying that the manufacturing facility of a (-)-Ketamine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting (-)-Ketamine APIs or (-)-Ketamine finished pharmaceutical products to another nation, regulatory agencies frequently require a (-)-Ketamine WC (written confirmation) as part of the regulatory process.
click here to find a list of (-)-Ketamine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing (-)-Ketamine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for (-)-Ketamine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture (-)-Ketamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain (-)-Ketamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a (-)-Ketamine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of (-)-Ketamine suppliers with NDC on PharmaCompass.
(-)-Ketamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (-)-Ketamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (-)-Ketamine GMP manufacturer or (-)-Ketamine GMP API supplier for your needs.
A (-)-Ketamine CoA (Certificate of Analysis) is a formal document that attests to (-)-Ketamine's compliance with (-)-Ketamine specifications and serves as a tool for batch-level quality control.
(-)-Ketamine CoA mostly includes findings from lab analyses of a specific batch. For each (-)-Ketamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(-)-Ketamine may be tested according to a variety of international standards, such as European Pharmacopoeia ((-)-Ketamine EP), (-)-Ketamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((-)-Ketamine USP).